Smart Medicine

Smart Medicine is an international open access journal covering the biological mechanisms of human diseases and medicine-related technologies, published by Wiley-VCH in partnership with the Wenzhou Institute of the University of Chinese Academy of Sciences since 2022, with a 2025 Journal Impact Factor of 12.8（Smart Medicine）是（Wiley-VCH）与中国科学院大学温州研究院合作出版的国际开放获取期刊，覆盖人类疾病的生物学机制与各类医学相关技术，创刊于 2022 年，2025 年影响因子为 12.8。

Scope

• It publishes original peer-reviewed articles that promote interdisciplinary research related to medicine, biomedical engineering and biotechnologies该刊发表原创同行评审文章，推动与医学、生物医学工程及生物技术相关的跨学科研究。^[1]
• Its medical and life science topics include oncology, immunology, pharmacy, internal medicine and epidemiology其医学与生命科学主题包括肿瘤学、免疫学、药学、内科学与流行病学。
• Its biomedical engineering topics include biomaterials, tissue engineering, organs-on-chips, drug delivery and nanotechnology其生物医学工程主题包括生物材料、组织工程、器官芯片、药物递送与纳米技术。^[2][3]
• Other engineering topics cover clinical diagnostics, bioelectronics, bioimaging, bioinformatics and medical artificial intelligence and robotics其他工程主题涵盖临床诊断、生物电子、生物成像、生物信息学以及医学人工智能与机器人。
• It accepts research articles, reviews, mini reviews and perspectives该刊接受研究论文、综述、短评与观点类文章。
• It also welcomes interdisciplinary communication between medicine and healthcare policy, humanities and education该刊还欢迎医学与医疗政策、人文学科及教育之间的跨学科交流。

History

• It was launched in 2022 and began publishing open access in the same year该刊于 2022 年创刊，并在同年以开放获取方式出版。
• It is published by Wiley-VCH in partnership with the Wenzhou Institute of the University of Chinese Academy of Sciences该刊由（Wiley-VCH）与中国科学院大学温州研究院合作出版。
• All articles are published under a CC BY license, so authors retain copyright and unrestricted publishing rights所有文章均以（CC BY）许可发表，作者保留版权与不受限制的出版权利。
• It is indexed in the Emerging Sources Citation Index, BIOSIS Previews, Biological Abstracts and the Directory of Open Access Journals该刊被（Emerging Sources Citation Index）、（BIOSIS Previews）、（Biological Abstracts）与（Directory of Open Access Journals）收录。
• Articles are deposited in PubMed Central, and the journal is archived in CLOCKSS and Portico文章被存入（PubMed Central），期刊并在（CLOCKSS）与（Portico）中归档。
• It publishes six issues a year, and its Journal Impact Factor rose from 11.6 in 2024 to 12.8 in 2025该刊每年出版 6 期，其影响因子由 2024 年的 11.6 上升至 2025 年的 12.8。

Editors

• Its Editors-in-Chief are Yihai Cao of the Karolinska Institute in Sweden and David A. Weitz of Harvard University in the United States其主编为瑞典（Karolinska Institute）的（Yihai Cao）与美国（Harvard University）的（David A. Weitz）。
• Its Executive Editor is Luoran Shang of Fudan University in China其执行编辑为中国（Fudan University）的（Luoran Shang）。
• Its Associate Editors include Renjie Chai of Southeast University in China, Sergey Filippov of the Leibniz Institute in Germany and Fangfu Ye of the Wenzhou Institute in China其副编辑包括中国（Southeast University）的（Renjie Chai）、德国（Leibniz Institute）的（Sergey Filippov）与中国（Wenzhou Institute）的（Fangfu Ye）。
• Other Associate Editors are Kenneth L. Pitter of Ohio State University in the United States and Cecilia Sahlgren of Eindhoven University of Technology in the Netherlands其他副编辑包括美国（Ohio State University）的（Kenneth L. Pitter）与荷兰（Eindhoven University of Technology）的（Cecilia Sahlgren）。
• Its broader editorial board has more than 20 members from over 10 countries and regions其编委会规模超过 20 名成员，来自 10 多个国家与地区。
• Editorial board members include Eben Alsberg of the University of Illinois at Chicago and Yu Shrike Zhang of Harvard Medical School编委会成员包括（University of Illinois at Chicago）的（Eben Alsberg）与（Harvard Medical School）的（Yu Shrike Zhang）。